carbamates has been researched along with Hypokalemic Periodic Paralysis in 1 studies
Hypokalemic Periodic Paralysis: An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Knock-in mutant mouse models of HypoPP (Cacna1s p." | 1.91 | Retigabine suppresses loss of force in mouse models of hypokalaemic periodic paralysis. ( Cannon, SC; DiFranco, M; Quiñonez, M; Wu, F, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quiñonez, M | 1 |
| DiFranco, M | 1 |
| Wu, F | 1 |
| Cannon, SC | 1 |
1 other study available for carbamates and Hypokalemic Periodic Paralysis
| Article | Year |
|---|---|
Retigabine suppresses loss of force in mouse models of hypokalaemic periodic paralysis.
Topics: Animals; Carbamates; Hypokalemic Periodic Paralysis; Mice; Muscle, Skeletal; Phenylenediamines | 2023 |